Euclidean Capital LLC Portfolio Holdings
Euclidean Capital LLC
- $735 Million
- Q4 2024
Euclidean Capital LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $735 Million distributed in 11 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Spdr S&P 500 ETF Trust with a value of $525M, Ishares Msci India Index Fund with a value of $128M, Vanguard Ftse All World Ex Us with a value of $58.2M, Oric Pharmaceuticals, Inc. with a value of $7.98M, and Foghorn Therapeutics Inc. with a value of $7.43M.
Examining the 13F form we can see an decrease of $170M in the current position value, from $906M to 735M.
Euclidean Capital LLC is based out at New York, NY
Below you can find more details about Euclidean Capital LLC portfolio as well as his latest detailed transactions.